---
title: "9 Health Care Stocks Moving In Wednesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282037204.md"
description: "In Wednesday's pre-market session, Quince Therapeutics (NASDAQ:QNCX) saw a significant gain of 98.6%, reaching $0.32, with a market cap of $9.0 million. Other gainers included Cypherpunk Technologies (NASDAQ:CYPH) up 16.59% to $0.85, and MapLight Therapeutics (NASDAQ:MPLT) up 15.99% to $28.0. Conversely, Cuprina Holdings (Cayman) (NASDAQ:CUPR) experienced the largest decline, falling 28.2% to $0.43. Talphera (NASDAQ:TLPH) and SILO Pharma (NASDAQ:SILO) also saw losses of 11.59% and 10.98%, respectively."
datetime: "2026-04-08T12:05:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282037204.md)
  - [en](https://longbridge.com/en/news/282037204.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282037204.md)
---

# 9 Health Care Stocks Moving In Wednesday's Pre-Market Session

### Gainers

-   **Quince Therapeutics** (NASDAQ:QNCX) stock moved upwards by 98.6% to $0.32 during Wednesday's pre-market session. The company's market cap stands at $9.0 million.
-   **Cypherpunk Technologies** (NASDAQ:CYPH) shares rose 16.59% to $0.85. The company's market cap stands at $65.6 million.
-   **MapLight Therapeutics** (NASDAQ:MPLT) shares increased by 15.99% to $28.0. The company's market cap stands at $1.0 billion.
-   **OKYO Pharma** (NASDAQ:OKYO) stock rose 15.62% to $1.85. The company's market cap stands at $83.9 million.
-   **Virax Biolabs Group** (NASDAQ:VRAX) stock moved upwards by 14.35% to $0.16. The market value of their outstanding shares is at $1.0 million.
-   **NewcelX** (NASDAQ:NCEL) stock increased by 13.94% to $2.37. The market value of their outstanding shares is at $9.4 million.

### Losers

-   **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) stock declined by 28.2% to $0.43 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.4 million.
-   **Talphera** (NASDAQ:TLPH) shares fell 11.59% to $0.7. The market value of their outstanding shares is at $39.6 million.
-   **SILO Pharma** (NASDAQ:SILO) stock fell 10.98% to $0.47. The company's market cap stands at $7.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SILO.US](https://longbridge.com/en/quote/SILO.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [MPLT.US](https://longbridge.com/en/quote/MPLT.US.md)
- [TLPH.US](https://longbridge.com/en/quote/TLPH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md)

## Related News & Research

- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Harvest Portfolios Group Inc. Grows Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/287027124.md)
- [Northwestern Mutual Wealth Management Co. Purchases 100,968 Shares of Medpace Holdings, Inc. $MEDP](https://longbridge.com/en/news/286744952.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)